Skip to content

Evaluation of the effect of vitamin C on some blood indicators of dialysis patients

Evaluation of the effect of vitamin C supplementation on selected blood laboratory indicators of chronic kidney diseases, a double blind randomized control trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100102002954N25
Enrollment
106
Registered
2022-01-31
Start date
2022-02-20
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease. Chronic kidney disease, stage 4 (severe)

Interventions

Intervention 1: Intervention group: for patients in the intervention group, after justifying the patients and providing the necessary training, routine treatment (including: hemodialysis, medication a

Sponsors

Shahroud University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with definitive diagnosis of chronic kidney disease and need dialysis; Age range 15-65 years; History of dialysis for at least six consecutive months; Stable vital signs; Have a controlled and consistent diet throughout the study; Conscious consent to participate in research.

Exclusion criteria

Exclusion criteria: Existence of digestive problems such as severe nausea and vomiting; Existence of severe and relatively severe coagulation problems; Existence of chronic heart and liver disease at the same time; Take any vitamin C supplements in the past month; Any changes in diet without notice during the study; Withdrawal or regret of conducting research at any stage of research.

Design outcomes

Primary

MeasureTime frame
Measurement of serum potassium. Timepoint: Once a month. Method of measurement: Standard laboratory method.;Measurement of serum calcium. Timepoint: Once a month. Method of measurement: Standard laboratory method.;Blood sugar measurement. Timepoint: Once a month. Method of measurement: Standard laboratory method.;Measurement of hemoglobin. Timepoint: Once a month. Method of measurement: Standard laboratory method.

Secondary

MeasureTime frame
Dialysis adequacy measurement. Timepoint: Once a month. Method of measurement: Dialysis adequacy indicators KT/V.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mehdi Feyzabadi

Shahroud University of Medical Sciences

mehdifyzabadi082@gmail.com+98 23 3234 2000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026